JangoBio therapies provide a complete hormone replacement solution for humans and animals. JangoBio utilizes regenerative stem-cell based precision medicine to restore circulating hormone balance required for optimal health and longevity. Headquartered near Madison, Wisconsin, JangoBio is an early-stage biotech company focused on developing new and novel methods to restore hormone balance in both humans and animals. Utilizing in-house advancements in regenerative stem-cell technology, JangoBio is developing a pipeline of first-in-class hormone restoration treatments. JangoBio recently completed a $2M seed round and is currently positioning itself for its next funding round and commercial revenue streams.
| Website | http://jango.bio |
| Revenue | $5.5 million |
| Employees | View employees |
| Founded | 2015 |
| Address | 2997 Yarmouth Greenway Dr, Fitchburg, Wisconsin 53711, US |
| Phone | +1 833-465-2646 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Life Science |
| Competitors | ExxonMobil, AstraZeneca, Amgen, BASF, DuPont, Novozymes, Codexis, Inc., Geno, Zymergen, Inc., Embody Biosciences +35 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular JangoBio employee's phone or email?
JangoBio Questions
The JangoBio annual revenue was $5.5 million in 2026.
JangoBio is based in Fitchburg, Wisconsin.
The NAICS codes for JangoBio are [32, 3254, 325].
The SIC codes for JangoBio are [283, 80, 28].
